Eli Lilly & Co. (LLY) Tops Q4 EPS by 21c, Updates FY Guidance

Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.73, $0.21 better than the analyst estimate of $1.52. Revenue for the quarter came in at $6.11 billion versus the consensus estimate of $5.91 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2020 EPS of $6.70-$6.80, versus the consensus of $6.76. Eli Lilly & Co. sees FY2020 revenue of $23.7-24.2 billion, versus the consensus of $23.82 billion.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Is Treasury selloff a major issue for stock market bulls?
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c